Although the Cnr1 inverse agonist rimonabant was an effective anti-obesity agent, it was often associated with affective disturbances such as anxiety and depression that made it unsuitable for routine use (22, 24, 25). This evidence concerns the gene CNR1 and obesity due to melanocortin 4 receptor deficiency.